Sequoia Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.4M | Buy |
14,373
+442
| +3% | +$197K | 0.04% | 242 |
|
|
2025
Q1 | $6.75M | Buy |
13,931
+1,041
| +8% | +$505K | 0.05% | 231 |
|
|
2024
Q4 | $5.19M | Buy |
12,890
+602
| +5% | +$242K | 0.05% | 251 |
|
|
2024
Q3 | $5.72M | Buy |
12,288
+1,147
| +10% | +$533K | 0.06% | 206 |
|
|
2024
Q2 | $5.22M | Buy |
11,141
+334
| +3% | +$157K | 0.06% | 185 |
|
|
2024
Q1 | $4.52M | Sell |
10,807
-3,569
| -25% | -$1.49M | 0.06% | 206 |
|
|
2023
Q4 | $5.85M | Buy |
14,376
+11,448
| +391% | +$4.66M | 0.07% | 198 |
|
|
2023
Q3 | $1.02M | Buy |
2,928
+199
| +7% | +$69.2K | 0.02% | 332 |
|
|
2023
Q2 | $960K | Buy |
2,729
+260
| +11% | +$91.5K | 0.02% | 354 |
|
|
2023
Q1 | $778K | Buy |
2,469
+110
| +5% | +$34.7K | 0.02% | 362 |
|
|
2022
Q4 | $681K | Buy |
2,359
+1,399
| +146% | +$404K | 0.02% | 372 |
|
|
2022
Q3 | $278K | Buy |
960
+20
| +2% | +$5.79K | 0.01% | 403 |
|
|
2022
Q2 | $265K | Buy |
+940
| New | +$265K | 0.01% | 478 |
|